Dr. Ralph Abraham resigned from his role as the Principal Deputy Director of the Centers for Disease Control and Prevention (CDC). While your information mentions his leadership of the Louisiana health department, his resignation actually occurred from his more recent, high-level federal position as the “No. 2” official at the CDC.
Abraham, who previously served as Louisiana’s Surgeon General, had only been in the federal role for ten weeks before stepping down, citing “unforeseen family obligations.”
Context: From Baton Rouge to Washington
Dr. Abraham’s career trajectory has been defined by rapid shifts and controversial public health stances that aligned with the current administration’s “Make America Healthy Again” (MAHA) movement.
Louisiana Tenure: As Surgeon General under Governor Jeff Landry, Abraham gained national attention for halting mass vaccination campaigns and stopping the state’s promotion of seasonal flu and COVID-19 shots, arguing for a “doctor-patient” choice model.
The Federal Pivot: In late 2025, he was appointed to the CDC by the Trump administration to help lead a major agency overhaul alongside Health Secretary Robert F. Kennedy Jr.
The Sudden Exit: His departure on Feb 23 leaves a significant vacancy at the CDC during a period of intense restructuring, including recent changes in the agency’s vaccine advisory panels.
Leadership Transition in Louisiana
Following Dr. Abraham’s move to the CDC in late 2025, Louisiana’s healthcare leadership has already seen a transition:
Current Health Secretary: Bruce Greenstein, who was appointed by Governor Landry in April 2025 to lead the Louisiana Department of Health (LDH).
Current Surgeon General: Dr. Evelyn Griffin, a Baton Rouge-based OB/GYN, who succeeded Abraham. Dr. Griffin has continued the policy shift toward more individualized vaccine recommendations, particularly regarding hepatitis B vaccines for newborns.
